Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...

Millions could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a report by KFF.

GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is ...

Millions of Americans may be eligible to get blockbuster GLP-1 drugs like Wegovy and Zepbound for a much lower price starting ...

Dr. Oz hopes the program's data will reveal how many eligible beneficiaries choose to take the drugs.

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as Medicare offers coverage for GLP-1 weight-loss drugs for ...

The Centers for Medicare & Medicaid Services launched the Medicare GLP-1 Bridge program, an initiative designed to test the impact of increased access to GLP-1 drugs for weight management among ...

Some Medicare beneficiaries could soon pay a flat $50 for GLP-1 drugs. Learn who qualifies, what employers may do, and what ...

Does Medicare pay for GLP-1 drugs like Ozempic for weight loss? For years, the answer has been a hard no. But a new “Bridge” ...

CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.